• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 3. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 4. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 5. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615

Recent Advances in the Study of 1-Benzhydrylazetidin-3-amine (CAS: 40432-52-8) and Its Applications in Chemical Biology and Medicine

1-Benzhydrylazetidin-3-amine (CAS: 40432-52-8) is a structurally unique compound that has garnered significant attention in the field of chemical biology and medicinal chemistry. Recent studies have explored its potential as a versatile scaffold for drug discovery, particularly in the development of novel therapeutics targeting central nervous system (CNS) disorders, infectious diseases, and cancer. This research brief synthesizes the latest findings on this compound, highlighting its synthesis, biological activity, and potential applications.

The compound's azetidine ring, coupled with the benzhydryl moiety, provides a rigid yet flexible framework that can be modified to enhance binding affinity and selectivity for various biological targets. Recent synthetic methodologies have focused on optimizing the yield and purity of 1-Benzhydrylazetidin-3-amine, with particular emphasis on green chemistry approaches to reduce environmental impact. Advances in catalytic asymmetric synthesis have also enabled the production of enantiomerically pure forms, which are critical for studying structure-activity relationships (SAR).

In terms of biological activity, 1-Benzhydrylazetidin-3-amine has shown promising results as a modulator of neurotransmitter receptors, including dopamine and serotonin receptors. Preclinical studies suggest its potential in treating neuropsychiatric conditions such as schizophrenia and depression. Additionally, its antimicrobial properties have been investigated, with some derivatives exhibiting potent activity against drug-resistant bacterial strains. The compound's ability to penetrate the blood-brain barrier (BBB) further enhances its therapeutic potential for CNS-targeted therapies.

Recent computational studies, including molecular docking and dynamics simulations, have provided insights into the binding modes of 1-Benzhydrylazetidin-3-amine with its biological targets. These studies have identified key interactions, such as hydrogen bonding and π-π stacking, which contribute to its high affinity and selectivity. Such findings are invaluable for the rational design of next-generation derivatives with improved pharmacokinetic and pharmacodynamic profiles.

Despite these advancements, challenges remain in the clinical translation of 1-Benzhydrylazetidin-3-amine-based therapeutics. Issues such as metabolic stability, toxicity, and scalability of synthesis need to be addressed. Ongoing research is exploring prodrug strategies and formulation technologies to overcome these hurdles. Collaborative efforts between academia and industry are expected to accelerate the development of this compound into viable drug candidates.

In conclusion, 1-Benzhydrylazetidin-3-amine represents a promising scaffold in chemical biology and medicinal chemistry. Its diverse biological activities and synthetic versatility make it a valuable tool for drug discovery. Future research should focus on optimizing its properties and expanding its therapeutic applications, paving the way for innovative treatments in various disease areas.

• 534618-36-5(3-Azetidinamine, N-decyl-1-(diphenylmethyl)-)
• 392231-64-0(3-Azetidinamine, 1-(diphenylmethyl)-N-(phenylmethyl)-)
• 147293-66-1(1-Benzhydryl-N-ethylazetidin-3-amine)
• 534618-46-7(3-Azetidinamine, N,1-bis(diphenylmethyl)-)
• 534618-25-2(3-Azetidinamine, 1-(diphenylmethyl)-N-(2-phenylethyl)-)
• 69159-49-5(1-benzhydryl-N-methyl-azetidin-3-amine)
• 102065-90-7(1-Benzhydrylazetidin-3-amine dihydrochloride)
• 1189735-08-7(1-Benzhydrylazetidin-3-amine hydrochloride)
• 133891-60-8(1-benzhydryl-N,3-dimethyl-azetidin-3-amine)
• 852655-92-6(3-Azetidinepropanenitrile,b-amino-1-(diphenylmethyl)-)